Be. Clausen et al., RESIDUAL MHC CLASS-II EXPRESSION ON MATURE DENDRITIC CELLS AND ACTIVATED B-CELLS IN RFX5-DEFICIENT MICE, Immunity, 8(2), 1998, pp. 143-155
Patients with major histocompatibility complex class II (MHC-II) defic
iency are known to carry mutations in either the RFX complex or the tr
ans-activator CIITA. While the pivotal role of CIITA for MHC-II gene t
ranscription is supported by the essential absence of MHC-II molecules
in CIITA-deficient mice, we demonstrate here that RFX5(-/-) mice reta
in expression of MHC-II in thymic medulla, mature dendritic cells, and
activated B cells. Nevertheless, RFX5(-/-) mice develop a severe immu
nodeficiency due to the lack of MHC-II in thymic cortex, failure of po
sitive selection of CD4(+) T cells, and absence of MHC-II on resting B
cells and resident or IFN gamma-activated macrophages. This different
ial requirement for CIITA and RFX5 in subsets of antigen-presenting ce
lls may be specific for the mouse; it may, however, also exist in huma
ns without having been noticed so far.